Screening assays and methods
Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.
1. A method comprising steps of:
contacting an array of subnanoliter volumes of liquid, each subnanoliter volume of liquid (i) being disposed in one of a plurality of microwells, and (ii) containing a single cell or a few cells and cell-derived products derived from said single cell or few cells, with a substantially planar surface of a solid substrate, wherein the substantially planar surface has at least one capture ligand immobilized thereon; the capture ligand being characterized in that, when exposed to cell-derived products, the capture ligand acts to retain at least one a cell-derived product of the cell-derived products from said single cell or few cells in association with the substantially planar surface; such that the at least one cell-derived product from each subnanoliter volume of liquid is retained by the capture ligand in association with the substantially planar surface in the region of the substantially planar surface contacted by the subnanoliter volume of liquid; wherein each microwell has a side or diameter of less than 100 microns, and wherein each microwell contains not more than a few cells; and
separating the substantially planar surface of the solid substrate from the array of subnanoliter volumes of liquid, wherein the at least one cell-derived product is retained in association with said region of the substantially planar surface of the solid substrate.
2. The method of claim 1 , wherein each microwell is dimensioned to hold up to about 10 nanoliters of liquid and one to a few cells.
3. The method of claim 1 , wherein said contacting and separating steps are completed in less than a day.
4. The method of claim 1 , further comprising after said separating step a step of contacting the array of subnanoliter volumes of liquid with a substantially planar surface of an additional substrate having an additional capture ligand immobilized thereon.
5. The method of claim 4 , wherein the capture ligand and the additional capture ligand are the same.
6. The method of claim 4 , wherein the capture ligand and the additional capture ligand are different.
7. The method of claim 1 , further comprising a step of determining identity or amount of the at least one cell-derived product.
8. The method of claim 7 , wherein the determining step is carried out by fluorescence detection, mass spectrometry, surface plasmon resonance, or a colorimetric assay.
9. The method of claim 7 , wherein the determining step is conducted using a fluorescence microscope, a fluorimeter, or a camera.
10. The method of claim 7 , wherein the determining step is conducted using an instrument comprising a charged coupled device, a photomultiplier tube, or a diode array.
11. The method of claim 7 , further comprising a step of detecting at least one phenotypic feature of the single cell or few cells in each microwell, so that a correlation between the phenotypic feature and identity or amount of the at least one cell-derived product is determined.
12. The method of claim 11 , further comprising extracting the single cell or few cells by micromanipulation.
13. The method of claim 1 , wherein the capture ligand is an antigen.
14. The method of claim 1 , wherein the capture ligand is a protein.
15. The method of claim 1 , wherein the capture ligand is an antibody.
16. The method of claim 1 , wherein the solid substrate is selected from the group consisting of a glass slide, a plastic slide, a metal plate, a porous filter material, and a rigid slab.
17. The method of claim 1 , wherein the at least one cell-derived product is a secreted cell-derived product.
18. The method of claim 17 , wherein the secreted cell-derived product is selected from the group consisting of an antibody, a cytokine, a chemokine, and an inflammatory mediator.
19. The method of claim 17 , wherein the secreted cell-derived product is an antibody.
20. The method of claim 19 , wherein the antibody is a monoclonal antibody.
21. The method of claim 17 , wherein the secreted cell-derived product is a cytokine or chemokine.
22. The method of claim 1 , wherein the at least one cell-derived product is or comprises a deoxyribonucleic acid, a ribonucleic acid, a polypeptide or a lipid.
23. The method of claim 1 , wherein the at least one cell-derived product is a non-secreted cell-derived product that is liberated from an intact cell upon lysis or permeabilization of said cell.
24. The method of claim 1 , wherein the at least one cell-derived product is a pathogen.
25. The method of claim 24 , wherein the at least one cell-derived product is a virus.
26. The method of claim 1 , wherein the single cell or few cells is or are eukaryotic, bacterial, yeast, or parasitic.
27. The method of claim 1 , wherein the single cell or few cells is or are an immune cell or immune cells.
28. The method of claim 1 , wherein the single cell or few cells is or are antibody-producing.
29. The method of claim 1 wherein the contacting is by reversibly sealing the solid substrate to the plurality of microwells.
30. The method of claim 29 wherein the sealing forms a substantially fluid tight seal.
31. The method of claim 1 wherein each microwell has a side or diameter of 10 to 100 microns.
32. The method of claim 1 wherein each microwell has a side or diameter of 50 to 100 microns.
33. The method of claim 1 wherein the solid substrate comprises a polymeric material.
34. The method of claim 1 wherein the solid substrate comprises a plastic material.
35. The method of claim 16 wherein the solid substrate is a glass slide.
36. The method of claim 14 wherein the protein recognizes the constant region of an antibody's structure.
37. The method of claim 1 , wherein the capture ligand is immobilized uniformly on the substantially planar surface of the solid substrate.
38. The method of claim 1 , further comprising after said separating step a step of detecting the retention of the at least one cell-derived product in association with said region of the substantially planar surface of the solid substrate.
39. The method of claim 1 wherein the at least one cell-derived product is a secreted monoclonal antibody, and said method further comprises after said separating step a step of exposing said region to a labeled antigen or labeled secondary antibody to determine if binding occurs between the at least one cell derived product and the labeled antigen or labeled secondary antibody.
40. A method comprising steps of:
contacting an array of subnanoliter volumes of liquid, each subnanoliter volume of liquid (i) being disposed in one of a plurality of microwells, and (ii) containing a single cell or a few cells and cell-derived products derived from said single cell or few cells, with a substantially planar surface of a solid substrate, wherein the substantially planar surface has at least one capture ligand immobilized thereon; the capture ligand being characterized in that, when exposed to cell-derived products, the capture ligand acts to retain at least one cell-derived product of the cell-derived products from said single cell or few cells in association with the substantially planar surface; such thatthe at least one cell-derived product from each subnanoliter volume of liquid is retained by the capture ligand in association with the substantially planar surface in the region of the substantially planar surface contacted by the subnanoliter volume of liquid; wherein there are greater than 625 microwells per square inch in the plurality of microwells, wherein each microwell contains not more than a few cells; and
separating the substantially planar surface of the solid substrate from the array of subnanoliter volumes of liquid, wherein the at least one cell-derived product is retained in association with said region of the substantially planar surface of the solid substrate.
41. The method of claim 40 , wherein the capture ligand is a protein.
42. The method of claim 41 wherein the protein recognizes the constant region of an antibody's structure.
43. The method of claim 42 wherein the protein is Protein A or Protein G.
44. The method of claim 40 , wherein the solid substrate is selected from the group consisting of a glass slide, a plastic slide, a metal plate, a porous filter material, and a rigid slab.
45. The method of claim 44 wherein the solid substrate is a glass slide.
46. The method of claim 40 wherein the solid substrate comprises a polymeric material.
47. The method of claim 40 wherein the substrate comprises a plastic material.
48. The method of claim 40 , wherein the at least one cell-derived product is a secreted cell-derived product.
49. The method of claim 48 , wherein the secreted cell-derived product is an antibody.
50. The method of claim 49 , wherein the antibody is a monoclonal antibody.
51. The method of claim 40 wherein the contacting is by reversibly sealing the solid substrate to the plurality of microwells.
52. The method of claim 51 wherein the sealing forms a substantially fluid tight seal.
53. The method of claim 40 , wherein the capture ligand is immobilized uniformly on the substantially planar surface of the solid substrate.
54. The method of claim 40 , further comprising after said separating step a step of detecting the retention of the at least one cell-derived product in association with said region of the substantially planar surface of the solid substrate.
55. The method of claim 40 wherein the at least one cell-derived product is a secreted monoclonal antibody, and said method further comprises after said separating step a step of exposing said region to a labeled antigen or labeled secondary antibody to determine if binding occurs between the at least one cell derived product and the labeled antigen or labeled secondary antibody.
56. The method of claim 40 wherein the solid substrate comprises a polymeric material.
57. The method of claim 1 , wherein the at least one cell-derived product is a product liberated from an intact cell upon lysis or permeabilization of the cell.
58. The method of claim 1 , wherein the at least one cell-derived product is selected from the group consisting of an antibody, cytokine, chemokine, inflammatory mediator, DNA, RNA, lipid, and combinations thereof.